of the German Stem Cell Network (GSCN) November 3-5, 2014 · 2020-04-10 · 2nd International...
Transcript of of the German Stem Cell Network (GSCN) November 3-5, 2014 · 2020-04-10 · 2nd International...
Prog
ram
& A
bstr
acts
www.gscn.orgwww.gscn.org
2nd A
nnua
l Con
fere
nce
2014
of th
e Ge
rman
Ste
m C
ell N
etw
ork
(GSC
N) i
n He
idel
berg
www.gscn.org
of the German Stem Cell Network (GSCN)November 3-5, 2014German Cancer Research Center (DKFZ)Heidelberg
2nd Internati onal Annual Conference
Conference Program
www.eppendorf.comDASGIP® is a registered trademark of DASGIP Information and Process Technology GmbH, Juelich, Germany. Eppendorf® and the Eppendorf logo are registered trademarks of Eppendorf AG, Hamburg, Germany. All rights reserved, including graphics and images. Copyright ©2014 by Eppendorf AG.
> Small working volumes starting at 35mL> Reduced shear forces thanks to adapted impeller designs> Precise control and online monitoring of temperature, oxygen tension, pH and agitation> Comprehensive data management
Eppendorf parallel DASGIP Bioreactor Systems perfectly meet the demands for optimal expansion of stem cells.The parallel operation, precise control and best scalability allow for most effective processing. DASGIP Parallel Bioreactor Systems are proven for various ES, MS & iPS cell lines.
DASGIP® Bioreactor Systems for Stem Cells – Observe, Control, Expand
Expand your Cells
Eppendorf Bioprocess Solutions:The Smart and Effective Way to Cultivate your Stem Cells.
gscn_programmheft_epp_ad_148x210_2014_08.indd 1 28.08.14 10:59GSCN_Titelseite_Programm_A5_2014 Kopie.indd 1-3 21.10.14 09:28
2nd International Annual Conference of the GSCN November 3 – 5, 2014 I DKFZ Heidelberg, Germany
14
Program
MONDAY, November 3rd
11:00–12:00 Registrationandlightlunch
OpeningLecture hall:12:00–12:05 WelcometotheGermanCancerResearchCenter(DKFZ):
Otmar Wiestler(ChairmanandScientificDirector,DKFZ)12:05–12:15 Andreas Trumpp(ActingPresident,GSCN)12:15–12:30 Openingremarks
Bärbel Brumme-Bothe(DepartmentHead“LifeSciences”,BMBF)12:30–13:15 Keynote lecture I
K1-Exploringthehierarchicalorganizationofcolorectalcancer Eduard Batlle;InstituteforResearchinBiomedicineBarcelona,Spain (Chair: Andreas Trumpp) supported by Eppendorf AG
13:15–14:00 Keynote lecture II K2-MyocardialregenerationbyESC-derivedcardiacprogenitors Philippe Menasché;HospitalEuropeanGeorgePompidou,Paris,France (Chair: Ulrich Martin)
14:00–14:30 Coffeebreak / industryexhibition
Concurrent scientific working group session ILecture hall: Stem cells in regenerative therapies I (chair: Ulrich Martin / Hans-Dieter Volk)14:30–14:50 Stemcellsinregenerativetherapies–Introduction
Ulrich Martin;Rebirth / HannoverMedicalSchool14:50–15:05 T01-Intranasaldeliveryofmigratoryneuralstem/progenitorcells:Anon-
invasivepassagetotherapeuticallytargetintracerebralbraintumors Nils Ole Schmidt;UniversityMedicalCenter,Hamburg-Eppendorf
15:05–15:20 T02-MicroRNA-181apromoteshumanneuronaldifferentiationbydown-regulatinggenesinvolvedinneuralstemcellmaintenance Laura Stappert;InstituteofReconstructiveNeurobiology,Bonn
15:20–15:35 T03-Pulmonarytransplantationofmultipotent-orpluripotent-stemcellderivedmacrophagesasanoveltreatmentoptionforpulmonaryalveolarproteinosis Nico Lachmann; Hannover Medical School
15:35–15:50 T04-HumaniPSC-derivedMSC-likeprogenitorcells:functionaldifferencesfromprimaryMSCsaffectingtheiruseincartilageregenerativemedicine Solvig Diederichs;UniversityHospitalHeidelberg
15:50–16:00 Groupdiscussion
Conferenceprogram 15
Room K 1: Stem cells in disease: cancer stem cells (chair: Thomas Brabletz / Andreas Trumpp)14:30–14:50 Conceptsofcancerstemcells–Introduction
Andreas Trumpp;GermanCancerResearchCenter,Heidelberg14:50–15:05 T05-Shp2Signalingisessentialtothesuppressionofsenescenceinmammary
gland cancer stem cells in mice Linxiang Lan;MaxDelbrückCenter,Berlin
15:05–15:20 T06-Humanizationofmousemodelsforhumanbreastcancerusingmesenchymalstemcells Maxine Silvestrov;ExperimentalPharmacology&Oncology(EPO)GmbH,Berlin
15:20–15:35 T07-Targetingthekinometoinducedifferentiationinhumanbreastcancerstem cells Jochen Maurer;UniversityMedicalCenterFreiburg
15:35–15:50 T08-CD151+cellsdrivetumor-initiation,hierarchicalgrowthandproliferation-associatedsignalinginpatient-derivedmodelsofserousovariancancer Franziska Zickgraf;GermanCancerResearchCenter,Heidelberg
15:50–16:00 Groupdiscussion
Room K 2: Computational stem cell biology (chair: Georg Fuellen / Ingo Roeder)14:30–14:45 Computationalstemcellbiology–Overviewandintroduction
Ingo Roeder;DresdenUniversityofTechnology14:45–14:55 T09-Whatmakesstemcellsmove?Studyingstemcellmigrationinvitro
(back-to-backpresentationwithT10) Michael Ansorge;LeipzigUniversity
14:55–15:05 T10-Whatmakesstemcellsmove?Studyingstemcellmigrationinsilico (back-to-backpresentationwithT09) Axel Krinner;DresdenUniversityofTechnology
15:05–15:20 T11-Characterizingtranscriptionalcell-to-cellheterogeneitiesduringstemcelldifferentiation Fabian Theis;HelmholtzCenterMunich
15:20–15:35 T12-Anetwork-basedstrategytodirectcellfatedetermination Antonio del Sol;LuxembourgCenterforSystemsBiomedicine
15:35–15:50 T13-Computationalidentificationofpluripotencynetworks Maryam Nazarieh;SaarlandUniversity,Saarbrücken
15:50–16:00 Groupdiscussion
ZMBH (groundfloor): Somatic stem cells (chair: Thomas Braun / Ana Martin-Villalba)14:30–14:50 Studiesonsomaticstemcells–anintroduction
Thomas Braun;MaxPlanckInst.f.HeartandLungRes.,BadNauheim14:50–15:05 T14-TheRNAhelicaseDDX6regulatescell-fatespecificationinneuralstem
cells via miRNAs Sarah Nicklas;LuxembourgCenterforSystemsBiomedicine
15:05–15:20 T15-AngiogenesiscontrolsneuralstemcellexpansionbyregulatingtissueoxygenationandHIFsignaling Christian Lange; VIBKULeuvenCampus,Belgium
Conferenceprogram
2nd International Annual Conference of the GSCN November 3 – 5, 2014 I DKFZ Heidelberg, Germany
16
15:20–15:35 T16-Regulationofasymmetric/symmetricstemcelldivisioninhumanepidermis Katharina Nöske;GermanCancerResearchCenter,Heidelberg
15:35–15:50 T17-Clonalheterogeneitywithintheexocrinepancreas Damian Wollny;GermanCancerResearchCenter,Heidelberg
15:50–16:00 Groupdiscussion
16:00–16:15 Coffeebreak / industryexhibition
16:15 – 18:15 Poster session I: P001 – P097 supported by Fluidigm Europe B�V� (posterswillbedisplayedinthetent) P001–P017:Pluripotencyandembryonicstemcells P018–P038:Programingandreprograming P039–P061:Stemcellsindevelopment P062–P072:Somaticstemcells (posterswillbedisplayedinfrontofroomK1+2) P073–P097:Hematopoieticstemcells
Evennumbers:pleasepresentyourposterfrom16:15–17:15 Unevennumbers:17:15–18:15
18:15–19:15 Dinner
Lecture hall:19:15–20:45 GSCNGeneralMembershipMeeting20:45–21:30 Get-together
Conferenceprogram 17
TUESDAY, November 4th
Concurrent scientific working group session IILecture hall: Stem cells in disease modeling and drug development
(chair: Oliver Brüstle / Karl-Ludwig Laugwitz) supported by Lonza Cologne GmbH
09:00–09:20 Theuseofstemcellsindiseasemodelinganddrugdevelopment–Overview Oliver Brüstle;InstituteofReconstructiveNeurobiology,Bonn
09:20–09:35 T18-ProbingmitochondrialDNAdisordersusingiPSC-derivedneuralprogenitors Alessandro Prigione; MaxDelbrückCenter,Berlin
09:35–09:50 T19-ModelingDravetsyndromeiniPScell-derivedneurons Matthias Hebisch;InstituteofReconstructiveNeurobiology,Bonn
09:50–10:05 T20-Thefunctionalityofstemcellderivedneurons:Howtodefineit? Sebastian Illes; Inst.ofMolecularReg.Medicine,Salzburg,Austria
10:05–10:20 T21-Modelingandpharmacologicalrescueofionchanneldiseasesenabledbyimprovedcardiacinductionofhumanpluripotentstemcellsin2Dand3Dformats Boris Greber;MaxPlankInstituteforMolecularBiomedicine,Münster
10:20–10:30 Groupdiscussion
Room K 1+2: Pluripotency and embryonic stem cells (chair: James Adjaye / Mathias Treier)09:00–09:20 Pluripotencyandembryonicstemcells:Introductionandoverview
James Adjaye; UniversityHospitalofDüsseldorf09:20–09:35 T22-Primate-specificendogenousretrovirusdriventranscriptiondefines
naïve-like stem cells Jichang Wang;MaxDelbrückCenter,Berlin
09:35–09:50 T23-AnovellncRNA-proteininteractioncharacterizesmouseembryonicstemcell fate Debojyoti Chakraborty;DresdenUniversityofTechnology
09:50–10:05 T24-NANOGandCDX2patterndistinctsubtypesofhumanmesodermduringexitfrompluripotency Sasha Mendjan;CambridgeStemCellInstitute,UnitedKingdom
10:05–10:20 T25-Insightsfromthestreak:identificationofnovelgenesassociatedwithgerm-layerformationandmesendodermdifferentiation Cantas Alev;RIKENCenterforDevelopmentalBiology,Kobe,Japan
10:20–10:30 Groupdiscussion
ZMBH(groundfloor): Stem cells in development (chair: Jan Lohmann / Francesca Spagnoli)09:00–09:15 Stemcellsindevelopment–Overview
Jan Lohmann; Centre for Organismal Studies Heidelberg 09:15–09:30 T26-Tet-dependentprocessingof5-methylcytosineprotectsDNAmethylation
canyonsagainsthypermethylation Achim Breiling;GermanCancerResearchCenter,Heidelberg
Conferenceprogram
2nd International Annual Conference of the GSCN November 3 – 5, 2014 I DKFZ Heidelberg, Germany
18
09:30–09:45 T27-PIEZO2isrequiredformechanotransductioninhumanES-cell-derivedtouchreceptors Katrin Schrenk-Siemens;UniversityofHeidelberg
09:45–10:00 T28-Transcriptionalandepigeneticdynamicsunderlyingcelllineagecommitment Filippo M. Cernilogar;LudwigMaximilianUniversity,Munich
10:00–10:15 T29-Thehistone3lysine4methyltransferaseMll2primestheNxt2promoterforneuraldifferentiation Katrin Neumann;DresdenUniversityofTechnology
10:15–10:30 T30-Signalsfromtheinjurynicheincreasefatepotentialofadultneuralstemcells Enric Llorens Bobadilla;GermanCancerResearchCenter,Heidelberg
10:30–11:15 Coffeebreak / industryexhibition
Industry session: “Technologies from GSCN industry partners”Lecture hall: Main supporters11:15–11:20 Introduction(Andreas Trumpp)11:20–11:50 C01-HighthroughputscreeningusingiPSC-basedmodels
Jared Sterneckert;CRTDresden,representingPeproTechGmbH11:50–12:20 C02-Controllingexpansionandcardiomyogenicdifferentiationofhuman
pluripotentstemcellsinscalablesuspensionculture Robert Zweigerdt;MHHannover,representingEppendorfAG
12:20–12:50 C03-Rawmaterialsinthemanufactureofadvancedtherapiesmedicinal products:Qualityattributesandqualityassurance Bernd Leistler; CellGenix GmbH
Room K 1+2: Supporters11:15–11:20 Introduction(Michael Cross)11:20–11:50 C04–EfficientneuralandcardiacdifferentiationsystemsforiPSC
Mohan C. Vemuri;LifeTechnologiesGmbH11:50–12:20 C05-Cell-basedgenedeliveryleveragesconventionalimmunotherapyfor
cancer;TreatmentofadvancedgastrointestinalcancerinaphaseI/IItrialwithmodifiedautologousMSC_apceth_101 Volker Scherhammer;apcethGmbH&Co.KG
12:20–12:50 C06-Scalableenzyme-freeprotocolsfortheisolationandmaintenanceof humaninducedpluripotentstemcellswithoutmechanicalcolonyscraping Alexandra Blak;STEMCELLTechnologiesSARL
ZMBH(groundfloor): Supporters11:15–11:20 Introduction(Torsten Tonn)11:20–11:50 C07-Thefutureiscounting–DigitalanalysisofRNA,DNAandproteinbiomarkers
Maik Pruess;NanoStringTechnologiesGermanyGmbH11:50–12:20 C08–PrimateiPScellsastoolsforevolutionaryanalyses
Wolfgang Enard;LudwigMaximilliansUniversity,Munich;representing FluidigmEuropeB.V.
Conferenceprogram 19
12:20–12:50 C09–Buildingbridgesfromresearchtotherapy:Aroadmapforthesuccessfulgenerationofclinical-gradeiPSCs Thomas Fellner;LonzaCologneGmbH
12:50–14:30 Lunchbuffet / industryexhibition / posterviewing supported by STEMCELL Technologies SARL
13:15–14:15 Room K 1+2: Explainingscienceandmotivatingpeople–Outreachmaterialsfor stem cell research (Tobias Cantz / Ira Herrmann)
Concurrent strategic working group session ALecture hall: Career development (chairs: Hartmut Geiger / Insa Schröder)14:30–14:45 Careersinindustry, Andreas Bosio; MiltenyiGmbH,Berg.Gladbach14:45–15:00 Careersinscienceadministration,Hella Lichtenberg; DLRBonn15:00–15:15 Careersinacademia,Hartmut Geiger / Insa Schröder15:15–15:30 Paneldiscussion
Room K 1+2: Clinical trials and regulatory affairs I (chair: Andreas Kurtz / Torsten Tonn / Hans-Dieter Volk) supported by apceth GmbH & Co� KG
14:30–14:50 DevelopmentofiPScell-basedcardiactherapy Ulrich Martin, MH Hannover
14:50–15:10 Regulatorychallengesofstemcell-basedmedicinalproducts Egbert Flory;PaulEhrlichInstitute,Langen
15:10–15:30 Groupdiscussion
ZMBH(groundfloor): Large scale banking of human pluripotent stem cells – workshop (chair: Andreas Kurtz / Joana Namorado)
14:30–14:45 BiomedicalapplicationsofiPScelltechnology Angel Raya; CMRB Barcelona
14:45–15:00 Theneedforlarge-scaleiPSCcollections-apharmaperspective Alex Gutteridge;Pfizer
15:00–15:15 Deliveryofhumanpluripotentstemcellsfortherapy:PhaseIVoftheUKStemCellBankProject Lyn Healy;UKStemCellBank,SouthMimms,U.K.
15:15–15:30 Therelaunchofthehumanpluripotentstemcellregistry(hESCreg) Andreas Kurtz;BCRTBerlin
15:30–15:45 Shortbreak
Concurrent strategic working group session BLecture hall: Stem cell technologies (chair: Andreas Bosio / Frank Emmrich)15:45–15:50 Introduction:Andreas Bosio,MiltenyiGmbH,Berg.Gladbach15:50–16:05 Methodsofgeneticengineering
Claudio Mussolino; UniversityofFreiburg
Conferenceprogram
2nd International Annual Conference of the GSCN November 3 – 5, 2014 I DKFZ Heidelberg, Germany
20
16:05–16:20 Reprogrammingtechnologies Micha Drukker;HelmholtzCenterMunich
16:20–16:35 Methodsoflasercellprinting Boris Chichkov; LaserCenterHannover(LZH)
16:35–16:45 Groupdiscussion
Room K 1+2: Clinical trials and regulatory affairs II (chair: Andreas Kurtz / Torsten Tonn / Hans-Dieter Volk)
15:45–16:05 Placentaexpandedmesenchymal(PLX)cells–preclinicaldataforpreparingclinical trials Lena Pinzur;PluriStemTherapeuticsInc.,Haifa,Israel
16:05–16:25 PLXcells–frompreclinicaltoclinicalstudies–whatdidwelearnsofarfrombiomarkerstudies? Hans-Dieter Volk;Berlin-BrandenburgCenterforReg.Therapies(BCRT)
16:25–16:45 Paneldiscussions
ZMBH(groundfloor): Funding opportunities for young and advanced scientists (chair: Hartmut Geiger / Albrecht Müller)
15:45–16:30 FundingopportunitiesoftheDFGforstemcellscientistsatvariouscareerstages Eckard Picht;GermanResearchFoundation(DFG),Bonn
16:30–16:45 Groupdiscussion
16:45–17:15 Coffeebreak / industryexhibition
16:45–17:45 DKFZ Mensa:Meet-the-experttable:Stem cell technologies – genetic engineering (Claudio Mussolino) limited to 10 registered participants
17:15–19:15 Poster session II: P098 – P187 (posterswillbedisplayedinthetent) P098–P129:Stemcellsinregenerativetherapies P130–P161:Stemcellsindiseasemodelinganddrugdevelopment (posterswillbedisplayedinfrontofroomK1+2) P162–P178:Stemcellsindisease:Cancerstemcells P179–P187:Computationalstemcellbiology
Evennumbers:pleasepresentyourposterfrom17:15–18:15 Unevennumbers:18:15–19:15
19:15–20:00 FreebusshuttletoNetworkingEvening (busseswilldepartfromtheDKFZmainentrance)
20:00–01:00 NetworkingEveningwithdinnerbuffetatSchlosshotel“Molkenkur” Klingenteichstr.31,69117Heidelberg(www.molkenkur.de) (Opening:Oliver Brüstle)(includedintheregistrationfee) supported by CellGenix GmbH
Conferenceprogram 21
WEDNESDAY, November 5th
Concurrent scientific working group session IIILecture hall: Hematopoietic stem cells (chair: Anthony Ho / Claudia Waskow)09:00–09:20 Introduction“Hematopoieticstemcells”
Claudia Waskow;TechnicalUniversityDresden09:20–09:35 T31-Stroma-derivedosteopontinregulateshematopoieticstemand
progenitorcellsfunctionuponaging Novella Guidi;UniversityofUlm
09:35–09:50 T32-IdentificationofregulatorynetworksinHSCsandtheirimmediate progenyviaintegratedproteome,transcriptome,andDNAmethylomeanalysis Daniel Klimmeck;GermanCancerResearchCenter,Heidelberg
09:50–10:05 T33-Kitdeficiencyregulatesstablehumanhematopoieticstemcell engraftmentinmice Susann Rahmig;TechnicalUniversityDresden
10:05–10:20 T34-STAT5-regulatedmiRNA193bcontrolshematopoieticstemandprogenitorcellexpansionbyfinetuningcytokinesignaling Nadine Hätscher;UniversityHospitalFrankfurt
10:20–10:30 Groupdiscussion
Room K 1+2: Programming and reprogramming (chair: Micha Drukker / Frank Edenhofer)09:00–09:15 Introductiontore-programming
Frank Edenhofer;UniversityofWürzburg09:15–09:30 T35-SelectivegenedeliveryintohumaniPScellsbasedonCD30-targeted
lentiviralvectors Thorsten Friedel;PaulEhrlichInstitute,Langen
09:30–09:45 T36-GenerationofiPScellsfromyoungvs.agedcellsources–influenceofdonorageonreprogrammingefficiencyandgeneticstabilityofiPSclones Katarzyna Osetek;LEBAO / HannoverMedicalSchool
09:45–10:00 T37-MesenchymalstemcellsderivedfromiPScellsfromagedindividuals acquirefetalcharacteristics Lucas Spitzhorn; UniversityHospitalofDüsseldorf
10:00–10:15 T38-TRIM32,adualplayerregulatingtheentryandexitfrompluripotency Lamia’a Bahnassawy;UniversityofLuxembourg
10:15–10:30 T39-RobustgenerationofcardiomyocytesfromhumaniPScellsrequires precisemodulationofBmpandWntsignaling Asifiqbal Kadari;JuliusMaximiliansUniversity,Würzburg
DKFZ SR 4th floor: Stem cells in regenerative therapies II (chair: Michael Cross / Frank Emmrich)H2.04.073
The meeting point for this session is at the registration desk!09:00–09:15 IntroductiontosessionIIstemcellsinregenerativetherapies
Michael Cross;UniversityofLeipzig
Conferenceprogram
2nd International Annual Conference of the GSCN November 3 – 5, 2014 I DKFZ Heidelberg, Germany
22
09:15–09:30 T40-EfficientgenerationoffunctionallydefinediPSC-derivedhumanneuralstem/progenitorcellsandoligodendrocytes Giacomo Frati;SanRaffaeleScientificInstitute,Milan,Italy
09:30–09:45 T41-Agingaffectsthemesenchymalstemcellderivedoligodendrogenic / remyelinationactivities:implicationforapotentialtherapyofmultiplesclerosis Francisco J. Rivera;ParacelsusMedicalUniversity,Salzburg,Austria
09:45–10:00 T42-TheeuropeanprojectREBORNE:Multipotentmesenchymalstromalcellsand biomaterial for bone healing Alexander Erle;UlmUniversityHospital
10:00–10:15 T43-Identification,isolationandtargetedinhibitionofafibroblastlineageresponsibleforscarringandcancerstroma Yuval Rinkevich;StanfordInstituteforStemCellBiologyandRegenerativeMedicine,U.S.A.
10:15–10:30 T44-Proofingthe(Un)Proven:Provenorapprovedstemcelltherapies– thatisthequestion Bianca Büchner;CenterforEthicsandLawintheLifeSciences(CELLS),Hannover
10:30–11:00 Coffeebreak / industryexhibition
Concurrent workshopsLecture hall: Clinical relevance of animal models in stem cell research and regenerative
medicine (chair: Georg Duda / Frank Emmrich) (Workshopofthe‘RegenerativeMedicineInitiativeGermany(RMIG)’)
11:00–11:20 Introduction:Animalmodelsinresearchforregenerativemedicine Axel Haverich;Rebirth / HannoverMedicalSchool
11:20–11:30 Celltransplantationintopre-clinicalmodelsofretinaldegeneration Marius Ader; CenterforRegenerativeTherapiesDresden
11:30–11:40 Medicaldevicesandtheapplicationofstemcells Konrad Kohler;zrm,TübingenUniversityHospital
11:40–11:50 Regenerativemedicineforanagingsociety:Howrelevantareourcurrent animalmodels? Georg Duda;BCRTBerlin
11:50–12:00 Heterogeneity,age,comorbiditiesandthetranslationalfailure–canwedobetterinprojectingfrompreclinicalstemcellstudiestoclinicaltrials? Johannes Boltze;TRMLeipzig
12:00–12:10 Hurdlesforclinicaltranslationofregenerativestemcelltherapy– lessonslearnedfromthecardiacPhaseIIIPERFECTmulticentertrial Gustav Steinhoff;RTCRostock
12:10–12:30 Paneldiscussion
Room K 1+2: Big pharma and the stem cell field – matching expectations? (organizer:Oliver Brüstle / Ira Herrmann) (WorkshopoftheStemCellNetworkNorthRhineWestphalia)
Conferenceprogram 23
Panel: Oliver Brüstle;LIFE&BRAINGmbH,Bonn Ralf Heilker; BoehringerIngelheimPharmaGmbH&Co.KG,Div.ResearchGermany Jörg Hüser;BayerPharmaAG,LeadDiscoveryWuppertal Bert Klebl;LeadDiscoveryCenterGmbH,Dortmund Moderation:Ira Herrmann;StemCellNetworkNRW,Düsseldorf
ZMBH(groundfloor): Proceedings of the German Society for Stem Cell Research (GSZ e.V.) (chair: Jürgen Hescheler)
11:00–11:10 Introduction11:10–11:30 Sinusnodalcellsfrompluripotentstemcells
Robert David;ReferenceandTranslationCenterforCardiacStemCell Therapy(RTC),Rostock
11:30–11:50 Chondrogeniclineagedeterminationduringdifferentiationofmouseembryonicstem cells Jürgen Rohwedel;UniversityofLübeck
11:50–12:10 UseoftranscriptomicsandepigeneticapproachesinhumanESC-based developmentalneurotoxicology(DNT)testing Tanja Waldmann;UniversityofKonstanz
12:10–12:30 LongtermcultureofiPSC-derivedcardiomyocytesonmechanically-definedsubstrates Carlos Heras;UniversityofCologne
12:30–12:45 Shortbreak
Lecture hall:12:45–13:30 Keynote lecture III
K3-Molecularandcellularregulationofmusclestemcellsduringdevelopmentandregeneration Shahragim Tajbakhsh;InstitutePasteur,Paris,France (Chair: Oliver Brüstle)
13:30–15:00 Lunchbuffet / industryexhibition supported by Nanostring Technologies Germany GmbH
13:45–14:45 Room K 1+2:Explainingscienceandmotivatingpeople–Outreachmaterialsforstem cell research (Tobias Cantz / Ira Herrmann)
13:45–14:45 DKFZ Mensa:Meet-the-experttable:Stem cell technologies – laser printing (Boris Chichkov)and– reprogramming technologies (Micha Drukker) limited to 10 registered participants each
Closing ceremonyLecture hall:15:00–15:15 Posterawardceremoniesandannouncementofindustryquizwinners
(Daniel Besser; GSCN) supported by PeproTech GmbH
15:15–15:30 Outlookandclosingremarks Incomingpresident:Thomas Braun
Conferenceprogram
2nd International Annual Conference of the GSCN
24
15:30–16:15 Keynote lecture IV – Joined session with the 6th BMBF symposium – Adult neural stem cells (Chair: Magdalena Götz / Ana Martin-Villalba) K4-Modelinghumanbraindevelopmentanddiseasein3Dculture Jürgen Knoblich;InstituteofMolecularBiotechnology(IMBA) Vienna,Austria supported by Life Technologies GmbH
16:15–17:00 K5-Adulthippocampalneurogenesis:Whatarenewneuronsgoodfor? Andwhatisgoodforthem? Amelia Eisch;UTSouthwestern,Dallas,U.S.A.
17:00–17:45 K6-Amechanismforthesegregationofageinmammalianneuralstemcells Sebastian Jessberger; UniversityofZurich,Switzerland
End of GSCN conference
Announcements:18:30–20:00 PublicoutreacheventoftheGSCNincollaborationwiththeScheringStiftung
andtheDKFZ(inGerman) Stammzellen als Chance – Realität und Perspektiven PodiumsdiskussionzuraktuellenForschunginLaborundKlinik
Panel: Magdalena Götz(LMUMünchen),Anthony Ho(Uni.Heidelberg), Andreas Trumpp(DKFZ) Moderation:Stefanie Seltmann(DKFZ)
20:00–21:00 Receptionpublicoutreachevent
and
November 6th, 2014 – GSCN Satellite Event: 6th BMBF Symposium – Adult neural stem cellsTheprogramofthesatelliteeventisavailableatthereceptiondesk.
Supported by:
Conferenceprogram